NME
CVS icon

Notis-McConarty Edward’s CVS Health CVS Stock Holding History

Notis-McConarty Edward’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,695
Closed -$277K – 87
2024
Q2 		$277K Sell
4,695
-4,656
-50% -$291K 0.11% 81
2024
Q1 		$746K Sell
9,351
-9,211
-50% -$704K 0.29% 59
2023
Q4 		$1.47M Sell
18,562
-22,309
-55% -$1.59M 0.58% 43
2023
Q3 		$2.85M Sell
40,871
-13,163
-24% -$933K 1.16% 29
2023
Q2 		$3.74M Sell
54,034
-762
-1% -$54.2K 1.42% 26
2023
Q1 		$4.07M Buy
54,796
+105
+0.2% +$8.8K 1.62% 22
2022
Q4 		$5.1M Buy
54,691
+103
+0.2% +$9.94K 2.12% 16
2022
Q3 		$5.21M Sell
54,588
-115
-0.2% -$11.4K 2.33% 14
2022
Q2 		$5.07M Buy
54,703
+73
+0.1% +$7.13K 2.11% 15
2022
Q1 		$5.53M Buy
54,630
+15
+0% +$1.58K 1.97% 16
2021
Q4 		$5.63M Buy
54,615
+15
+0% +$1.39K 1.88% 17
2021
Q3 		$4.63M Buy
54,600
+1,945
+4% +$163K 1.7% 21
2021
Q2 		$4.39M Buy
52,655
+1,515
+3% +$124K 1.63% 22
2021
Q1 		$3.85M Buy
51,140
+175
+0.3% +$12.7K 1.5% 23
2020
Q4 		$3.48M Buy
50,965
+1,110
+2% +$72.2K 1.42% 25
2020
Q3 		$2.91M Hold
49,855
– – 1.28% 29
2020
Q2 		$3.24M Buy
49,855
+380
+0.8% +$23.9K 1.51% 22
2020
Q1 		$2.94M Buy
49,475
+690
+1% +$46.1K 1.63% 21
2019
Q4 		$3.62M Sell
48,785
-2,800
-5% -$197K 1.61% 22
2019
Q3 		$3.25M Buy
51,585
+695
+1% +$41.2K 1.53% 22
2019
Q2 		$2.77M Sell
50,890
-150
-0.3% -$8.08K 1.31% 26
2019
Q1 		$2.75M Buy
51,040
+15
+0% +$926 1.33% 26
2018
Q4 		$3.34M Sell
51,025
-145
-0.3% -$10.8K 1.84% 22
2018
Q3 		$4.03M Sell
51,170
-41
-0.1% -$2.93K 2.15% 19
2018
Q2 		$3.3M Sell
51,211
-280
-0.5% -$18.5K 1.95% 20
2018
Q1 		$3.2M Buy
51,491
+315
+0.6% +$22.6K 1.92% 21
2017
Q4 		$3.71M Buy
51,176
+5,650
+12% +$411K 2.13% 17
2017
Q3 		$3.7M Sell
45,526
-96
-0.2% -$7.59K 2.32% 17
2017
Q2 		$3.67M Buy
45,622
+525
+1% +$41.5K 2.38% 17
2017
Q1 		$3.54M Sell
45,097
-610
-1% -$48.7K 2.32% 16
2016
Q4 		$3.61M Buy
45,707
+81
+0.2% +$6.55K 2.48% 12
2016
Q3 		$4.06M Sell
45,626
-25
-0.1% -$2.36K 2.77% 8
2016
Q2 		$4.37M Buy
45,651
+210
+0.5% +$20.9K 3.07% 7
2016
Q1 		$4.71M Buy
45,441
+55
+0.1% +$5.35K 3.35% 4
2015
Q4 		$4.44M Sell
45,386
-268
-0.6% -$26.2K 3.18% 4
2015
Q3 		$4.4M Sell
45,654
-92
-0.2% -$9.67K 3.29% 2
2015
Q2 		$4.8M Buy
45,746
+600
+1% +$61.3K 3.24% 2
2015
Q1 		$4.66M Sell
45,146
-397
-0.9% -$40.2K 3.23% 3
2014
Q4 		$4.39M Buy
45,543
+150
+0.3% +$13.2K 3% 6
2014
Q3 		$3.61M Sell
45,393
-2,775
-6% -$219K 2.54% 7
2014
Q2 		$3.63M Buy
48,168
+875
+2% +$66.1K 2.4% 10
2014
Q1 		$3.54M Buy
47,293
+300
+0.6% +$21.2K 2.47% 10
2013
Q4 		$3.36M Buy
+46,993
New +$3.02M 2.36% 11

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Notis-McConarty Edward's CVS Position: Q3 2024 in Review

Notis-McConarty Edward sold out of CVS Health (CVS) in Q3 2024, closing a stake of 4,695 shares — an estimated $277K sold.

Notis-McConarty Edward first reported a position in CVS in Q4 2013 and held it in 43 quarters. The position peaked at $5.63M in Q4 2021. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Notis-McConarty Edward reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • Notis-McConarty Edward sold 4,695 CVS Health shares in Q3 2024, an estimated $277K.
  • Notis-McConarty Edward first reported a position in CVS Health in Q4 2013 and held it in 43 quarters.
  • Notis-McConarty Edward's CVS Health position peaked at $5.63M in Q4 2021.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Notis-McConarty Edward's 13F filing for Q3 2024, filed 12 Nov 2024.